The layoffs come three months after the company axed 150 positions in Sanford following a high-profile phase 3 trial failure for its Duchenne muscular dystrophy (DMD) gene therapy candidate.

With phase 3 miss, Pfizer's DMD candidate is no threat to Sarepta's Elevidys ahead of key label expansion: analysts Elevidys’ third-quarter sales hit CHF 108 million, beating consensus estimates ...

Sarepta’s gene therapy for Duchenne muscular dystrophy (DMD) will be an option for many more patients in the US after the FDA expanded the breadth of its approved labelling. Elevidys ...

How Much Does a Dentist Make? Dentists made a median salary of $155,040 in 2022. The best-paid 25% made $212,220 that year, while the lowest-paid 25% made $105,480. The states and districts that ...

Its discoveries intend to treat hemophilia, Huntington’s disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in ...

The only other gene therapies to have made it to market so far are uniQure’s Glybera’s (alipogene tiparvovec), and GSK’s Strimvelis, but both have only gained EU approval. Glybera is a case ...

Some people live a full life with MD. Others, including those diagnosed with Duchenne muscular dystrophy (DMD), typically have lived into their teens and 20s. Muscular dystrophy, a genetic disease ...

What is the best career fit for me? Take our assessment now. Finding your dream job starts with knowing what makes you the way you are. Simple Statements that relate to you. Unique Be yourself ...

If you experience severe pain, contact your dentist for advice. If you’re nervous about the procedure, let your dentist know and they may be able to offer you dental sedation to help you relax. How do ...